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syphilis (titer > 1:8) 0.20%, trichomonas 2.4%, HIV 0.17%.
The overall prevalences of STIs in the female sex workers14th International Congress on Infectious Diseases (ICID) Abs
sepsis. Emergent laporatomy revealed extensive myometrial
infarction and necrosis with conﬁrmed GAS infection. Her
ICU course was complicated by MOF with acute renal and
hepatic insufﬁciency and thrombocytopenia.
A forth, and nearly fatal puerperal GAS infection involved
a young womanwho presented ﬁve days after a vaginal deliv-
ery with fever, chills, and abdominal pain. Her prolonged
hospital course was complicated by MOF and peripheral
necrosis, with loss of limbs.
Conclusion: This report highlights the return of serious
GAS puerperal sepsis. The fulminant nature of GAS sep-
sis poses important diagnostic and therapeutic challenges.
Recent reports suggest GAS remains a formidable pathogen
late in pregnancy and raises the question of whether GAS
should be included in antenatal screening programs. The
presence of GAS in vaginal culture may have signiﬁcant clin-
ical implications. The pathogenicity and capacity of this
organism to cause overwhelming, life-threatening infection
warrants further study to determine the true incidence of
vaginal contamination in late pregancny and the potential
efﬁcacy of antibiotic prophylaxis.
doi:10.1016/j.ijid.2010.02.532
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plex virus type 2 prevalence among antenatal women in
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Background: Herpes simplex virus type 2 (HSV-2), the
most common cause of genital ulcer disease worldwide has
shown increasing evidence to have synergistic activity on
human immunodeﬁciency virus (HIV) acquisition by two fold
or more. So, there was a need to know the prevalence
of HSV-2 to develop intervention strategy especially in the
high HIV prevalent states of northeast India. A study was
therefore conducted among antenatal women to assess the
prevalence of HSV-2 infection as well the role of spouse’s
circumcision on HSV-2 prevalence.
Methods: A total of 1640 antenatal women from ﬁve
different northeastern states of India, namely Assam,
Arunachal Pradesh, Manipur, Meghalaya and Mizoram with
diverse ethnic background were enrolled after informed
consent. They were screened for IgG antibody status against
HSV-2 using HerpeSelect 2 ELISA IgG kits form Focus Diagnos-
tics, USA. A structured questionnaire was used to evaluate
different risk variables.
Results: The median age of the subjects was 24 years
(SD± 4.8) with inter quartile age of 22-28 years. The overall
prevalence of HSV-2 (IgG) positive was 8.6%, while preva-
lence was highest in Arunachal Pradesh (15%) and was lowest
in Manipur (2.74%). There was a signiﬁcant association of
HSV-2 infection with history of vaginal discharge with pelvic
pain (p = 0.0001) and genital ulcer (p = 0.02). Regular con-
dom user’s had a low HSV-2 prevalence of 1% compared
to 10.3% in infrequent or non-condom users (OR = 11.1,
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5% C.I. = 3.5 — 35.2, p < 0.0001). HSV-2 prevalence was
.7% in women with circumcised spouses compared to 9.2%
mong uncircumcised spouse (OR = 5.7, 95% C.I. = 1.4- 23.4,
= 0.01). Prevalence was low among Muslims (3.8%) com-
ared to 12.6% among Christians (p = 0.0001)
Conclusion: The study documented a variable difference
f prevalence of HSV-2 among the different states of north-
ast India. The important ﬁnding of independent association
ith spouse’s circumcision with HSV-2 sero-status in preg-
ant women brings to light the importance of circumcision
n decreasing the transmission of HSV-2 in the community.
his may be of vital importance as it can be implemented
s a modiﬁable preventive measure to decrease the preva-
ence of HSV-2 which will ultimately help in lowering the HIV
revalence in the community.
oi:10.1016/j.ijid.2010.02.533
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he ‘‘PREVEN’’ urban community randomised trial of a
ombined intervention for sexually transmitted disease
revention in Nepal
.P. Bhandari 1,∗, S.D. Joshi2
Commuity Health and Environmental Society Nepal, KTM,
epal
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Background: A community randomized trial, (PREVEN
rial), was conducted to explore the impact of combined
exually transmitted disease interventions in urban Nepal.
Methods: The intervention were: (1) improved syndromic
anagement of vaginal and urethral discharge available
hrough pharmacies, with social marketing of condoms and
reatment packages and referral to previously trained physi-
ians for cases of pelvic inﬂammatory disease and genital
lcers, and (2) screening and treatment of sex workers (SW)
eached through a mobile team every two months, along
ith presumptive treatment for trichomoniasis (TV) and bac-
erial vaginosis with metronidazole, and provision of free
ondoms. A baseline survey of STIs prevalence was under-
aken in the general population (GP) and amongst SW and
heir clients in 4 cities in 2005 to stratify cities for ran-
omisation to intervention and control arms of the trial.3
ities were selected for the trial. The impact of the inter-
entions, was evaluated through surveys of STI prevalence.
esting for syphilis, GC, CT, TV and HIV were undertaken in
he 20 randomised cities. Data analysis was blinded with
espect to city identity until results were available for
ach infection where upon the prevalence of each infec-
ion in the matched intervention and control cities could be
ompared.
Results: The overall prevalences of STIs in the general
opulation across the cities were as follows: males: gon-
rrhea 0.11%, Chlamydia 4.7%, syphilis (titer > 1:8) 0.29%,
IV 0.51%; females: gonorrhea 0.24%, Chlamydia 8.6%,cross the cities were as follows: gonorrhea 1.2%, Chlamy-
ia 17.6%, syphilis (titer > 1:8) 1.3%, trichomonas 3.7%,
IV 0.41%.
